Now showing items 1-3 of 3

    • Clinical Research Environment in India: Challenges and Proposed Solutions. 

      Burt, T; Sharma, P; Dhillon, S; Manchanda, M; Mittal, S; Trehan, N (J Clin Res Bioeth, 2014-11-01)
      India has compelling need and keen aspirations for indigenous clinical research. Notwithstanding this need and previously reported growth the expected expansion of Indian clinical research has not materialized. We reviewed ...
    • PARTAKE survey of public knowledge and perceptions of clinical research in India. 

      Alam, S Munir; Alapati, B; Burt, T; Dhillon, S; Jain, S; Khan, D; Mittal, S; ... (10 authors) (PLoS One, 2013)
      BACKGROUND: A public that is an informed partner in clinical research is important for ethical, methodological, and operational reasons. There are indications that the public is unaware or misinformed, and not sufficiently ...
    • Pharmacogenomics in early-phase clinical development. 

      Burt, T; Dhillon, S (Pharmacogenomics, 2013-07)
      Pharmacogenomics (PGx) offers the promise of utilizing genetic fingerprints to predict individual responses to drugs in terms of safety, efficacy and pharmacokinetics. Early-phase clinical trial PGx applications can identify ...